FDA Inspection 1180578 — Gulf Coast Regional Blood Center - Humble
The FDA completed an inspection of Gulf Coast Regional Blood Center - Humble on Aug 31, 2022 in Humble, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 31, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Humble, TX (United States)